DRS. Jason Kim and Steven Weissbart from Pelvic health and continence center for women has Stony Brook University Hospital (Sbuh) managed to play one of the first in the country – and the very first on the east coast – GLAN ™ Urodynamics Procedures using the ambulatory urodynamic system of Bright Uro.
This innovative diagnostic technology represents significant increase in the assessment of the function of the bladder for the 17 million estimated people who have daily bladder control problems in the United States. Unlike traditional urodynamic studies that require catheterization and observation in a clinical framework, Glean ™ allows real -time data collection in an outpatient and real environment – offering a more natural experience for patients while improving the accuracy of diagnosis, safety and global comfort. Patients diagnosed with dysfunction of the lower urinary tract and the search for symptoms that are difficult to capture during traditional urodynamic tests in progress can benefit from wireless wireless monitoring of the bladder pressure system, which is certain.
Jason Kim, MD, an associate professor of urology and director of Women’s Pelvic Health and Continence Center de Sbuh, was the national principal for the trial approved by the FDA of the Glean ™ system. The results of this pivot test were recently published in the Journal of Endourology.
“We are proud to be at the forefront of urological innovation,” said Dr. Kim. “This new technology marks a major step in patient centered care by providing a more physiological and less invasive approach to urodynamic tests.
As the country’s second site – and the first on the East Coast – to implement this advanced technology, SBUH continues to conduct care for patients with pelvic floor disorders and lower urinary tract symptoms.